Genome editing tools, such as CRISPR-Cas9 and newer base-editing technologies, offer the potential to standardize ALS models and reduce variability by precisely manipulating genetic mutations associated with ALS, such as C9orf72 expansions, SOD1 mutations, or TDP-43 mislocalization. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.